OpenBilldrug price receipt

NADAC week of 2026-10-14

AMRIX ER 15 MG CAPSULE

FDA nonproprietary name: cyclobenzaprine hydrochloride

For 30 capsules

Pharmacies pay

$1,986.98 filed

30 × $66.23256 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-01-01 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$2,290.03 estimated

$1,986.98 + $298.05 (15%) + $5.00 fee per fill = $2,290.03

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-01-01 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

AMRIX ER 15 MG CAPSULE is how the CMS NADAC file names this product. The FDA NDC Directory lists it as cyclobenzaprine hydrochloride, under the trade name “AMRIX”.

FDA gives its dosage form as capsule, extended release and its route as oral.

The labeler, the company named on the label, is Cephalon, LLC.

FDA’s Established Pharmacologic Class for it is Muscle Relaxant.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 63459-0700-60.

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $1,986.98 for 30 capsules (30 × $66.23256 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-01-01. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 4, carried forward from the previous file.

This NDC’s NADAC was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: it took effect on 2026-01-01. The file is new; the price is not.

NADAC also lists, on the row of one brand NDC, what pharmacies pay for the generic equivalent, a different product: $1.18556 per EA filed.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

The NDC

Other strengths, forms and brands

8 other products in the NADAC file share the FDA nonproprietary name cyclobenzaprine hydrochloride with AMRIX ER 15 MG CAPSULE.

ProductPharmacies pay per unitMedicare per unit
AMRIX ER 15 MG CAPSULE this page
brand · capsule, extended release
$66.23256 per EA filed
eff. 2026-01-01
We don’t know yet
AMRIX ER 30 MG CAPSULE
brand · capsule, extended release
$66.56709 per EA filed
eff. 2026-01-01
We don’t know yet
CYCLOBENZAPRINE 5 MG TABLET
generic · tablet, film coated / tablet
$0.02197 per EA filed
eff. 2026-09-23
$0.14207 per EA filed
Part D 2024 average
CYCLOBENZAPRINE 7.5 MG TABLET
generic · tablet, film coated
$0.26288 per EA filed
eff. 2026-09-23
$0.14207 per EA filed
Part D 2024 average
CYCLOBENZAPRINE 10 MG TABLET
generic · tablet, film coated / tablet
$0.01712 per EA filed
eff. 2026-09-23
$0.14207 per EA filed
Part D 2024 average
CYCLOBENZAPRINE ER 15 MG CAP
generic · capsule, extended release
$1.18556 per EA filed
eff. 2026-09-23
We don’t know yet
CYCLOBENZAPRINE ER 30 MG CAP
generic · capsule, extended release
$1.0822 per EA filed
eff. 2026-09-23
We don’t know yet
FEXMID 7.5 MG TABLET
generic · tablet
$0.26288 per EA filed
eff. 2026-09-23
$0.14207 per EA filed
Part D 2024 average
TONMYA 2.8 MG TABLET SL
brand · tablet, orally disintegrating
$29.60952 per EA filed
eff. 2026-09-23
We don’t know yet

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-01-01, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

Its NADAC price is $66.23256 per EA filed.

Of the 22 other products in FDA’s Muscle Relaxant class priced per EA, 1 has a higher middle NADAC price and 21 a lower one. The one in the middle is CARISOPRODOL 250 MG TABLET, at $0.47389 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-01-01, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.